BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SLC12A1
,
nitric oxide metabolic process
,
Pseudomonas infection
,
Stem cell
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
il 20
Summary
General Info
Curated Studies
Most Correlated Studies
IL-20 subfamily cytokines - effects on reconstituted human epidermis
Monocytes from healthy donors cultured with IL-10, IL-15, or IL-4
IL-1 treatment of human epidermal keratinocytes
Aortic smooth muscle cells treated with IL-1b
Naive and inflammatory memory T cells from F5 TCR transgenic mice treated with IL-7 and IL-4
Explore Curated Studies Results
Literature
Most Relevant Literature
IL-20 controls resolution of experimental colitis by regulating epithelial IFN/STAT2 signalling.
CsIL-20, a tongue sole interleukin-20, negatively mediates leucocyte activity and antibacterial defe…
Dual Role of Interleukin-20 in Different Stages of Osteoclast Differentiation and Its Osteoimmune Re…
Molecular identification and functional exploration of interleukin-20 in snakehead (Channa argus) in…
Increased expression of IL-20 is associated with ischemic cardiomyopathy and acute myocardial infarc…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis
Safety and Tolerability of Anti-IL-20 in Healthy Volunteers and Patients With Rheumatoid Arthritis
A Trial Investigating the Mechanism of Action of NNC0109-0012 (Anti-IL-20 mAb) Through Synovial Biop…
First Human Dose Study of Anti-IL-20 in Psoriasis: A Study of Safety, Tolerability and Early Signals…
A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Ar…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ